The propensity for long-acting cabotegravir and rilpivirine every 2 months among HIV-infected people eligible for treatment
Academic Article
Publication Date:
2023
Short description:
The propensity for long-acting cabotegravir and rilpivirine every 2 months among HIV-infected people eligible for treatment / Alberton, F., Nozza, S., Raccagni, A.R., Galli, L., Spagnuolo, V., Bossolasco, S., Cernuschi, M., Canetti, D., Hasson, H., Castagna, A., Gianotti, N.. - In: JOURNAL OF MEDICAL VIROLOGY. - ISSN 0146-6615. - 95:1(2023). [10.1002/jmv.28330]
Iris type:
1.1.2. Articolo in Rivista - Letter, Note
List of contributors:
Alberton, F.; Nozza, S.; Raccagni, A. R.; Galli, L.; Spagnuolo, V.; Bossolasco, S.; Cernuschi, M.; Canetti, D.; Hasson, H.; Castagna, A.; Gianotti, N.
Published in: